Redistribution of body composition in patients with Graves' disease after iodine-131 treatment

被引:5
|
作者
Xie, L-J [1 ]
Zhou, H-J [2 ]
Li, J-F [1 ]
Zhang, F. [1 ]
Zeng, F-W [1 ]
Qin, L-P [1 ]
Chen, Y. [1 ]
Yuan, H-J [1 ]
Cheng, M-H [1 ]
机构
[1] Sun Yat Sen Univ, Dept Nucl Med, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Dept Internal Med, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China
关键词
X-RAY ABSORPTIOMETRY; SERUM LEPTIN LEVELS; SKELETAL-MUSCLE; MASS INDEX; THYROID-HORMONE; RADIOIODINE TREATMENT; ENERGY-EXPENDITURE; HYPERTHYROIDISM; BONE; HYPOTHYROIDISM;
D O I
10.1038/ejcn.2014.232
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
OBJECTIVE: The objective of this study was to investigate body composition redistribution at 3 months after radioactive iodine therapy (RAI). METHODS: Eighty patients with Graves' disease (GD) for RAI and 18 volunteers were recruited. All patients underwent thyroid status test and dual-energy x-ray absorptiometry at baseline and 3 months after RAI. According to the second thyroid status test, patients were divided into the following groups: A, with aggravated hyperthyroidism; B-1, with improved hyperthyroidism; B-2, with euthyroidism; and B-3, with hypothyroidism. RESULTS: Total lean mass (LM) but fat mass (FM) and bone mineral content (BMC) of whole GD patients after RAI recovered to be not different with controls. Compared with baseline, in group A, FM in the left leg increased, and LM in left arm, right arm, trunk and total LM decreased (P<0.05). In B-2, FM in the head increased, and LM in the head, right arm, trunk and total LM increased (P<0.05). In B-3, FM in the right leg and total body fat percentage decreased, but FM in the head, android-to-gynoid fat ratio and body mass index increased (P<0.05); LM of all sites, weight and total mass increased (P<0.05); BMC in lumbar spine and left leg, and total BMC decreased (P<0.05). Body composition of unmentioned sites was retained after RAI in each group (P>0.05). CONCLUSIONS: Replenishment of LM gets priority rather than FM and BMC during the first 3 months after RAI, and the increase in LM starts from the upper body; head is the regional site in which FM recovery occurs first.
引用
收藏
页码:856 / 861
页数:6
相关论文
共 50 条
  • [31] Acute myeloid leukemia after iodine-131 treatment for thyroid disorders
    L. Laurenti
    P. Salutari
    S. Sica
    N. Piccirillo
    G. Zini
    M. Zollino
    G. Leone
    Annals of Hematology, 1998, 76 : 271 - 272
  • [32] Comparison of Fixed 10 mCi and 15 mCi Iodine-131 Doses for the Treatment of Graves' Disease: 11 Year Study
    Dede, Fuat
    Ones, Tunc
    Candemir, Sinem
    Novruzov, Fuad
    Gungor, Serkan
    Aras, Mustafa
    Ozguven, Salih
    Inanir, Sabahat
    Erdil, Tanju Yusuf
    Turoglu, Halil Turgut
    MARMARA MEDICAL JOURNAL, 2011, 24 (01): : 26 - 30
  • [33] Acute myeloid leukemia after iodine-131 treatment for thyroid disorders
    Laurenti, L
    Salutari, P
    Sica, S
    Piccirillo, N
    Zini, G
    Zollino, M
    Leone, G
    ANNALS OF HEMATOLOGY, 1998, 76 (06) : 271 - 272
  • [34] THYROID CANCER AFTER IODINE-131 THERAPY
    STARR, P
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1974, 227 (08): : 940 - 940
  • [35] THYROTROPIN (TSH) AFTER IODINE-131 THERAPY
    GIBBERD, M
    MCMILLAN, M
    STAFFURTH, JS
    LANCET, 1974, 1 (7865): : 1048 - 1048
  • [36] THYROID CANCER AFTER IODINE-131 THERAPY
    MCDOUGALL, IR
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1974, 227 (04): : 438 - 438
  • [37] THE THYROID GLAND AFTER TREATMENT OF THYROTOXICOSIS BY PARTIAL THYROIDECTOMY OR IODINE-131
    CURRAN, RC
    ECKERT, H
    WILSON, GM
    JOURNAL OF CLINICAL PATHOLOGY, 1958, 11 (04) : 373 - 373
  • [38] Therapeutic Iodine-131 Dose for Basedow Disease
    Canzi, C.
    Carletto, M.
    Longari, V.
    Castellani, M.
    Gerundini, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S168 - S168
  • [39] Iodine-131 treatment of hyperthyroidism: our experience
    Campenni', A.
    Ruggeri, R. M.
    Amato, E.
    Castorina, S.
    Raniolo, M.
    Ruggeri, A.
    Trimarchi, F.
    Benvenga, S.
    Baldari, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S424 - S424
  • [40] Iodine-131 tositumomab (Bexxar) for treatment of lymphoma
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2003, 45 (1168): : 86 - 87